Behaviorally Enhanced Messages to Increase Medical Check-ups(BEM-IMC)
BEM-IMC
1 other identifier
interventional
266
1 country
1
Brief Summary
The study had two stages. Stage 1 involved an opportunistic screening for hypertension conducted at the 2018 Beirut Marathon. During stage 1, participants whose measurements indicated hypertension were invited to take part in a RCT (randomized controlled trial). Stage 2 involved a RCT to evaluate the effectiveness of a behavioural intervention to increase the proportion of participants who sought further medical attention. The research team hypothesised that the intervention would increase the proportion of participants who sought further medical attention compared to a control group that did not receive the intervention. This is a retrospective registration specifically focused on the RCT component of this study. The study was conducted by Nudge Lebanon in partnership with B4- development (formerly known as QBIU) and SmartScience. The RCT was not pre-registered because the collaborators were unaware that pre-registration would be necessary. The collaborators asked the University of Warwick to re-analyse and write the project up for publication after the study was complete. The University of Warwick is now seeking to retrospectively register the trial before submitting to an academic journal. The fact that this trial is retrospectively registered will be plainly stated in the manuscript and all analyses will be presented as exploratory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Nov 2018
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2019
CompletedFirst Submitted
Initial submission to the registry
March 23, 2020
CompletedFirst Posted
Study publicly available on registry
March 27, 2020
CompletedMarch 27, 2020
March 1, 2020
2 months
March 23, 2020
March 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-reported seeking of further medical attention.
If participants tell the researcher that they sought further medical attention via a phone call they received approximately 1 month after the WhatsApp messages were sent to participants.
Response taken 56 days after the opportunistic screening (1 = Yes-sought further medical attention, 0 = No)
Secondary Outcomes (5)
Self-reported Hypertension
A survey response taken at the opportunistic screening.(1 = Yes-experiencing hypertension, 0 = No)
Self-reported Diabetes
A survey response taken at the opportunistic screening.(1 = Yes-experiencing diabetes, 0 = No)
Self-reported High Cholesterol
A survey response taken at the opportunistic screening.(1 = Yes-experiencing high cholesterol, 0 = No)
Systolic blood pressure (SBP)
An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor
Diastolic blood pressure (DBP)
An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor
Other Outcomes (13)
Heart rate
An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor
year of birth
A survey response taken at the opportunistic screening.
Height in cm
A survey response taken at the opportunistic screening.
- +10 more other outcomes
Study Arms (2)
Intervention
EXPERIMENTALParticipants in this group received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition.
Control
NO INTERVENTIONParticipants in this group did not received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition.
Interventions
The experimentally evaluated part of the intervention is a WhatsApp message. The message translated from Arabic to English appears below. "Dear \[First name\], Your BP reading during Beirut Marathon was \[reading\]. This indicates that you have elevated blood pressure. You should seek medical attention at your earliest convenience. Your wellbeing matters to us. Nudge Lebanon team"
Eligibility Criteria
You may qualify if:
- objectively taken measurements at opportunistic screening indicated hypertension,
- provided informed consented to participate in the trial, and
- provided valid contact details for a smart phone with WhatsApp messenger
You may not qualify if:
- n/a
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kelly Ann Schmidtkelead
- B4Development Foundation (Supreme Committee for Delivery and Legacy)collaborator
- Nudge Lebanoncollaborator
- University of Warwickcollaborator
Study Sites (1)
Nudge Lebanon. 3rd Floor, GS Building, Sit Nasab Street
Beirut, Lebanon
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fadi Makki, PhD
B4Development Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The researchers who called participants to ask if they sought further medical attention was not made aware of the participants' conditions.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 23, 2020
First Posted
March 27, 2020
Study Start
November 7, 2018
Primary Completion
January 10, 2019
Study Completion
January 10, 2019
Last Updated
March 27, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share
The research team will cannot make identifiable individual participant data available. The de-identified participant data used in this papers analyses can be made available by contacting Kelly Ann Schmidtke (ORCID identifier: 0000-0001-5993-0358) and can be reused for further analyses.